Form 4: AMN Healthcare Director Reports Stock Transactions
Statement of Changes in Beneficial Ownership
AMN Healthcare director Jorge A. Caballero reported transactions involving the acquisition of common stock through the vesting of restricted stock units.
Summary
- Director Jorge A. Caballero acquired 8,325 shares of AMN Common Stock on May 1, 2026, due to the vesting of Restricted Stock Units (RSUs).
- These RSUs were granted under the AMN Healthcare 2017 Equity Plan.
- Additionally, 8,304 RSUs were granted on May 1, 2026, under the AMN Healthcare 2025 Equity Plan, which are set to vest on the one-year anniversary of the grant date or the Company's 2027 Annual Meeting of Shareholders, whichever comes first.
- Following these transactions, Caballero beneficially owns 15,462 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine equity vesting and grants for a director, rather than a significant strategic event or financial performance indicator.
Positives
- Director Jorge A. Caballero's beneficial ownership of AMN Healthcare stock has increased through the vesting of RSUs.
- The acquisition of 8,325 shares represents the fulfillment of prior equity awards.
- The granting of new RSUs indicates continued incentive alignment for management.
Future Outlook
The filing indicates that 8,304 RSUs granted on May 1, 2026, are expected to vest on the earlier of the one-year anniversary of the grant date or the date of the Company's Annual Meeting of Shareholders in 2027.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, reflecting typical equity-based compensation practices within the healthcare services industry.
Stakeholder Impact
- Shareholders: The transaction reflects standard executive compensation and does not immediately impact share count or ownership structure in a significant way beyond the director's holdings.
Next Steps
- Monitoring the vesting of the 8,304 RSUs granted on May 1, 2026, which is expected by May 1, 2027, or the 2027 Annual Meeting of Shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Date of earliest transaction reported; vesting of RSUs and grant of new RSUs. |
| 05/02/2025 | Grant date for a portion of the RSUs that vested on 05/01/2026. |
| 05/04/2026 | Date the Form 4 was signed. |
Keywords
AMN Healthcare, Form 4, Insider Trading, Stock Vesting, Restricted Stock Units, Equity Plan, Director Transactions, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.